Potential Role of pNF-H, a Biomarker of Axonal Damage in the Central Nervous System, as a Predictive Marker of Chemotherapy-Induced Cognitive Impairment

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2775
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Establishing a Model for Assessing DNA Damage in Murine Brain Cells as a Molecular Marker of Chemotherapy-Associated Cognitive Impairment

Life Sciences
GeneticsMolecular BiologyPharmacologyBiochemistryMedicineToxicologyPharmaceutics
2013English

Cerebrospinal Fluid Presepsin as a Marker of Nosocomial Infections of the Central Nervous System: A Prospective Observational Study

Frontiers in Neurology
Neurology
2018English

Development of a Central Nervous System Axonal Myelination Assay for High Throughput Screening

BMC Neuroscience
NeuroscienceCellularMolecular Neuroscience
2016English

The Identification of a Possible Biomarker for Cognitive Impairment

Journal of the Neurological Sciences
Neurology
2015English

Central Nervous System Impairment in Effort Syndromes.

BMJ
1988English

Tissue-Level Thresholds for Axonal Damage in an Experimental Model of Central Nervous System White Matter Injury

Journal of Biomechanical Engineering
Biomedical EngineeringPhysiology
2000English

Phosphorylated Heat Shock Protein 27 as a Potential Biomarker to Predict the Role of Chemotherapy-Induced Autophagy in Osteosarcoma Response to Therapy

Oncotarget
Oncology
2017English

The Role of Microbiome in Central Nervous System Disorders

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2014English

Potential Role of Serum Homocysteine and Uric Acid Level as a Predictive Marker for Pre-Eclampsia

International Journal of Scientific Reports
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy